GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Clinical trial NCT03154918 · UNKNOWN

Trial details

NCT number: NCT03154918
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Extranodal NK-T-Cell

Start date: 2017-06-01
Primary completion: 2020-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.